0.00Open0.00Pre Close0 Volume0 Open Interest65.00Strike Price0.00Turnover0.00%IV-91.63%PremiumMay 16, 2025Expiry Date31.08Intrinsic Value100Multiplier6DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.10Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Establishment Labs Stock Discussion
Just Released: Motiva's FDA-Approved Implants Achieve Remarkable 88.5% Patient Success Rate
📊⚡️📊
Establishment Labs Receives U.S. FDA Approval for Motiva Implants
• $A10 Networks (ATEN.US)$ +10.6% (to join S&P SmallCap 600)
• $SVB Financial (SIVB.US)$ +8.9% (earnings report)
• $Revance Therapeutics(Delisted) (RVNC.US)$ +8.9% (FDA accepts BLA resubmission for DaxibotulinumtoxinA for Injection)
• $UFP Industries (UFPI.US)$ +5.9% (also increases dividend)
• $JD.com (JD.US)$ +3.8% (weighing payment of special cash dividend)
• $Establishment Labs (ESTA.US)$ +3.4% (Presentation of 2-Year Results from Motiva US...
No comment yet